Connection

Heather Boger to Animals

Back to Details
This is a "connection" page, showing publications Heather Boger has written about Animals.
Heather Boger
Connection Strength
0.711
Animals
  1. Differential effects of vagus nerve stimulation paradigms guide clinical development for Parkinson's disease. Brain Stimul. 2020 Sep - Oct; 13(5):1323-1332.
    View in: PubMed
    Score: 0.052
  2. Effects of vagus nerve stimulation are mediated in part by TrkB in a parkinson's disease model. Behav Brain Res. 2019 11 05; 373:112080.
    View in: PubMed
    Score: 0.049
  3. Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease. Brain Stimul. 2017 Nov - Dec; 10(6):1045-1054.
    View in: PubMed
    Score: 0.043
  4. Altered glutamate release in the dorsal striatum of the MitoPark mouse model of Parkinson's disease. Brain Res. 2016 11 15; 1651:88-94.
    View in: PubMed
    Score: 0.040
  5. Effects of aging on glutamate neurotransmission in the substantia nigra of Gdnf heterozygous mice. Neurobiol Aging. 2015 Mar; 36(3):1569-76.
    View in: PubMed
    Score: 0.035
  6. Short-term effects of an endotoxin on substantia nigra dopamine neurons. Brain Res. 2014 Apr 04; 1557:164-70.
    View in: PubMed
    Score: 0.033
  7. Glial cell-line derived neurotrophic factor (GDNF) replacement attenuates motor impairments and nigrostriatal dopamine deficits in 12-month-old mice with a partial deletion of GDNF. Pharmacol Biochem Behav. 2013 Mar; 104:10-9.
    View in: PubMed
    Score: 0.031
  8. Prenatal LPS increases inflammation in the substantia nigra of Gdnf heterozygous mice. Brain Pathol. 2011 May; 21(3):330-48.
    View in: PubMed
    Score: 0.027
  9. Enhanced dopamine transporter activity in middle-aged Gdnf heterozygous mice. Neurobiol Aging. 2012 Feb; 33(2):427.e1-14.
    View in: PubMed
    Score: 0.027
  10. Effects of brain-derived neurotrophic factor on dopaminergic function and motor behavior during aging. Genes Brain Behav. 2011 Mar; 10(2):186-98.
    View in: PubMed
    Score: 0.027
  11. A dual-hit animal model for age-related parkinsonism. Prog Neurobiol. 2010 Feb 09; 90(2):217-29.
    View in: PubMed
    Score: 0.025
  12. Minocycline restores striatal tyrosine hydroxylase in GDNF heterozygous mice but not in methamphetamine-treated mice. Neurobiol Dis. 2009 Mar; 33(3):459-66.
    View in: PubMed
    Score: 0.023
  13. Differential effects of the dopamine neurotoxin MPTP in animals with a partial deletion of the GDNF receptor, GFR alpha1, gene. Brain Res. 2008 Nov 19; 1241:18-28.
    View in: PubMed
    Score: 0.023
  14. Long-term consequences of methamphetamine exposure in young adults are exacerbated in glial cell line-derived neurotrophic factor heterozygous mice. J Neurosci. 2007 Aug 15; 27(33):8816-25.
    View in: PubMed
    Score: 0.021
  15. A partial GDNF depletion leads to earlier age-related deterioration of motor function and tyrosine hydroxylase expression in the substantia nigra. Exp Neurol. 2006 Dec; 202(2):336-47.
    View in: PubMed
    Score: 0.020
  16. Comparative Enhancement of Motor Function and BDNF Expression Following Different Brain Stimulation Approaches in an Animal Model of Ischemic Stroke. Neurorehabil Neural Repair. 2020 10; 34(10):925-935.
    View in: PubMed
    Score: 0.013
  17. Spinophilin-deficient mice are protected from diet-induced obesity and insulin resistance. Am J Physiol Endocrinol Metab. 2020 08 01; 319(2):E354-E362.
    View in: PubMed
    Score: 0.013
  18. Calpain mediated expansion of CD4+ cytotoxic T cells in rodent models of Parkinson's disease. Exp Neurol. 2020 08; 330:113315.
    View in: PubMed
    Score: 0.013
  19. Inhibitory designer receptors aggravate memory loss in a mouse model of down syndrome. Neurobiol Dis. 2020 02; 134:104616.
    View in: PubMed
    Score: 0.012
  20. Diet-induced insulin resistance elevates hippocampal glutamate as well as VGLUT1 and GFAP expression in A?PP/PS1 mice. J Neurochem. 2019 01; 148(2):219-237.
    View in: PubMed
    Score: 0.012
  21. 5-HT1F receptor-mediated mitochondrial biogenesis for the treatment of Parkinson's disease. Br J Pharmacol. 2018 01; 175(2):348-358.
    View in: PubMed
    Score: 0.011
  22. Enhanced Cognition and Hypoglutamatergic Signaling in a Growth Hormone Receptor Knockout Mouse Model of Successful Aging. J Gerontol A Biol Sci Med Sci. 2017 03 01; 72(3):329-337.
    View in: PubMed
    Score: 0.010
  23. Accumbens nNOS Interneurons Regulate Cocaine Relapse. J Neurosci. 2017 01 25; 37(4):742-756.
    View in: PubMed
    Score: 0.010
  24. Effects of fingolimod administration in a genetic model of cognitive deficits. J Neurosci Res. 2017 05; 95(5):1174-1181.
    View in: PubMed
    Score: 0.010
  25. Memory and hippocampal architecture following short-term midazolam in western diet-treated rats. Neurosci Lett. 2016 05 16; 621:68-74.
    View in: PubMed
    Score: 0.010
  26. Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome. Curr Alzheimer Res. 2016; 13(1):35-52.
    View in: PubMed
    Score: 0.010
  27. Cocaine Self-Administration and Extinction Leads to Reduced Glial Fibrillary Acidic Protein Expression and Morphometric Features of Astrocytes in the Nucleus Accumbens Core. Biol Psychiatry. 2016 08 01; 80(3):207-15.
    View in: PubMed
    Score: 0.010
  28. BDNF levels are increased by aminoindan and rasagiline in a double lesion model of Parkinson?s disease. Brain Res. 2016 Jan 15; 1631:34-45.
    View in: PubMed
    Score: 0.009
  29. Gq-DREADD Selectively Initiates Glial Glutamate Release and Inhibits Cue-induced Cocaine Seeking. Biol Psychiatry. 2015 Oct 01; 78(7):441-51.
    View in: PubMed
    Score: 0.009
  30. Designer receptors enhance memory in a mouse model of Down syndrome. J Neurosci. 2015 Jan 28; 35(4):1343-53.
    View in: PubMed
    Score: 0.009
  31. Estrogen receptor alpha deficiency protects against development of cognitive impairment in murine lupus. J Neuroinflammation. 2014 Dec 16; 11:171.
    View in: PubMed
    Score: 0.009
  32. Evidence of altered age-related brain cytoarchitecture in mouse models of down syndrome: a diffusional kurtosis imaging study. Magn Reson Imaging. 2015 May; 33(4):437-47.
    View in: PubMed
    Score: 0.009
  33. Synaptic glutamate spillover due to impaired glutamate uptake mediates heroin relapse. J Neurosci. 2014 Apr 16; 34(16):5649-57.
    View in: PubMed
    Score: 0.008
  34. Three-dimensional rodent motion analysis and neurodegenerative disorders. J Neurosci Methods. 2014 Jul 15; 231:31-7.
    View in: PubMed
    Score: 0.008
  35. A noradrenergic lesion exacerbates neurodegeneration in a Down syndrome mouse model. J Alzheimers Dis. 2011; 23(3):471-89.
    View in: PubMed
    Score: 0.007
  36. Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome. Behav Brain Res. 2011 Aug 10; 221(2):610-22.
    View in: PubMed
    Score: 0.006
  37. The nigrostriatal dopamine system of aging GFRalpha-1 heterozygous mice: neurochemistry, morphology and behavior. Eur J Neurosci. 2008 Oct; 28(8):1557-68.
    View in: PubMed
    Score: 0.006
  38. Mood, memory and movement: an age-related neurodegenerative complex? Curr Aging Sci. 2008 Jul; 1(2):133-9.
    View in: PubMed
    Score: 0.006
  39. Effects of glial cell line-derived neurotrophic factor deletion on ventral mesencephalic organotypic tissue cultures. Brain Res. 2007 Feb 16; 1133(1):10-9.
    View in: PubMed
    Score: 0.005
  40. Partial deletion of glial cell line-derived neurotrophic factor (GDNF) in mice: Effects on sucrose reward and striatal GDNF concentrations. Brain Res. 2006 Jan 12; 1068(1):257-60.
    View in: PubMed
    Score: 0.005
  41. Glial cell line-derived neurotrophic factor is essential for neuronal survival in the locus coeruleus-hippocampal noradrenergic pathway. Neuroscience. 2004; 124(1):137-46.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.